Case History: JANUVIA™ (Sitagliptin), a Selective Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 Diabetes

被引：13
|
作者：
Weber, Ann E. [1 ]
Thornberry, Nancy [2 ]
机构：
[1] Merck Res Labs, Dept Med Chem, Rahway, NJ 07065 USA
[2] Merck Res Labs, Dept Metab Disorders, Rahway, NJ 07065 USA
来源：
ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 42 | 2007年 / 42卷
关键词：
D O I：
10.1016/S0065-7743(07)42007-3
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
[No abstract available]
引用
收藏
页码：95 / 109
页数：15
相关论文
共 50 条
  • [21] Alogliptin benzoate.: Dipeptidyl-peptidase IV (DPP IV) inhibitor, treatment of type 2 diabetes
    Wang, Y.
    Serradell, N.
    Rosa, E.
    Bolos, J.
    DRUGS OF THE FUTURE, 2008, 33 (01) : 7 - 12
  • [22] Dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes: Focus on sitagliptin
    Herman, G. A.
    Stein, P. P.
    Thornberry, N. A.
    Wagner, J. A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 (05) : 761 - 767
  • [23] Renoprotective Effects of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin: A Review in Type 2 Diabetes
    Mega, Cristina
    Teixeira-Lemos, Edite
    Fernandes, Rosa
    Reis, Flavio
    JOURNAL OF DIABETES RESEARCH, 2017, 2017
  • [24] Inhibition of the activity of dipeptidyl peptidase IV as a treatment for type 2 diabetes
    Holst, JJ
    Deacon, CF
    DIABETES, 1998, 47 (11) : 1663 - 1670
  • [25] Protective effects of the dipeptidyl peptidase IV inhibitor sitagliptin in the blood-retinal barrier in a type 2 diabetes animal model
    Goncalves, A.
    Leal, E.
    Paiva, A.
    Teixeira Lemos, E.
    Teixeira, F.
    Ribeiro, C. F.
    Reis, F.
    Ambrosio, A. F.
    Fernandes, R.
    DIABETES OBESITY & METABOLISM, 2012, 14 (05): : 454 - 463
  • [26] Evogliptin: a new dipeptidyl peptidase inhibitor for the treatment of type 2 diabetes
    Tan, Xueying
    Hu, Jingbo
    EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (09) : 1285 - 1293
  • [27] Dipeptidyl peptidase IV (DPP-IV) inhibition as a treatment for type 2 diabetes
    Thornberry, N.
    FEBS JOURNAL, 2009, 276 : 77 - 77
  • [28] Dipeptidyl peptidase IV (DP-IV) inhibition as a treatment for Type 2 diabetes
    Thornberry, N
    FASEB JOURNAL, 2004, 18 (08): : C120 - C120
  • [29] Dipeptidyl peptidase IV (DPP-IV) inhibition as a treatment for Type 2 diabetes
    Thornberry, NA
    FASEB JOURNAL, 2005, 19 (05): : A1723 - A1723
  • [30] Effects of the Dipeptidyl Peptidase-4 Inhibitor, Sitagliptin, on Colorectal Carcinogenesis in a Model of Type 2 Diabetes
    Inoue, Takuya
    Yorifuji, Naoki
    Fujiwara, Kaori
    Sakanaka, Taisuke
    Iguchi, Munetaka
    Narabayashi, Ken
    Okada, Toshihiko
    Nouda, Sadaharu
    Kakimoto, Kazuki
    Ishida, Kumi
    Kawakami, Ken
    Abe, Yosuke
    Takeuchi, Toshihisa
    Umegaki, Eiji
    Higuchi, Kazuhide
    GASTROENTEROLOGY, 2014, 146 (05) : S654 - S655
12345